Impact Journalism Day by Sparknews: A better community - No. 16

Low-cost phototherapy cures jaundice in babies

D-Rev's two models of its Brilliance phototherapy device have been used in treating 117,500 babies since 2012.
D-Rev's two models of its Brilliance phototherapy device have been used in treating 117,500 babies since 2012.PHOTO: D-REV

LAGOS (Nigeria) • Brilliance, a low-cost high-quality phototherapy device, is being used for the treatment of jaundice in babies.

Over six million babies requiring treatment for severe jaundice each year are not receiving treatment. When left untreated, severe jaundice can result in disability or death. With the device, D-Rev, a non-profit medical device development company, aims to increase access to effective phototherapy.

Launched in 2012, the company's two health products - Brilliance Pro Classic and Brilliance Pro - have been used in treating 117,500 babies with jaundice.

 

To make it user-friendly, Brilliance is designed to be easily integrated with other critical medical equipment. Also, it can withstand power fluctuations.

"We believe Brilliance Pro will help us reach further, giving under-served communities access to world-class healthcare," said D-Rev chief executive Krista Donaldson.

A version of this article appeared in the print edition of The Straits Times on June 25, 2016, with the headline 'Low-cost phototherapy cures jaundice in babies'. Print Edition | Subscribe